Home > Insider Trading > Filing (0000899243-20-027697)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662579	C4 Therapeutics Inc.	CCCC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1132945	A Marc Cohen	C/O C4 Therapeutics, Inc. 490 Arsenal Way, Suite 200 Watertown MA 02472		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-06	237,149	$0.00	370,024	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-06	1,482,183	$0.00	1,852,207	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-06	2,484,425	$0.00	2,484,425	No	4	C	Indirect	By Cobro Ventures Opportunity Fund, L.P.
Common Stock	Acquisiton	2020-10-06	5,030	$19.00	5,030	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	By Cobro Ventures Opportunity Fund, L.P.
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series Seed Preferred Stock	Disposition	2020-10-06	2,000,000	$0.00	237,149	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-10-06	12,500,000	$0.00	1,482,183	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-10-06	20,952,403	$0.00	2,484,425	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.
Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.